APO-DIPYRIDAMOLE 100 MG
DIPYRIDAMOLE : 100 MG · DIN 02220571 · APOTEX INC
Health Canada status: CANCELLED PRE MARKET
What is APO-DIPYRIDAMOLE?
APO-DIPYRIDAMOLE 100 MG contains DIPYRIDAMOLE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02220571, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 21-Jul-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02220571 |
|---|---|
| Brand name | APO-DIPYRIDAMOLE |
| Generic / active ingredient | DIPYRIDAMOLE : 100 MG |
| Manufacturer | APOTEX INC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | B01AC07 DIPYRIDAMOLE |
| AHFS class | 24:12.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 21-Jul-2024 |
What can be used instead?
Other Canadian products sharing ATC code B01AC07 DIPYRIDAMOLE. 2 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIPYRIDAMOLE INJECTION, USP | 5 MG | LIQUID | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02244475 |
| PERSANTINE | 5 MG | SOLUTION | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | MARKETED | DIN 00637734 |
| APO-DIPYRIDAMOLE | 25 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895644 |
| APO-DIPYRIDAMOLE | 50 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895652 |
| APO-DIPYRIDAMOLE | 75 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895660 |
| APO-DIPYRIDAMOLE-SC TAB 25MG | 25 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00571237 |
| APO-DIPYRIDAMOLE-SC TAB 50MG | 50 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00571245 |
| APO-DIPYRIDAMOLE-SC TAB 75MG | 75 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00601845 |
| DIPYRIDAMOLE 25 TAB 25MG | 25 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00579580 |
| DIPYRIDAMOLE 50 TAB 50MG | 50 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00579572 |
Who else supplies DIPYRIDAMOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DIPYRIDAMOLE appears in 15 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.